Page last updated: 2024-10-26

doxepin and Acute Lymphoid Leukemia

doxepin has been researched along with Acute Lymphoid Leukemia in 2 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dworsky, ZD1
Bennett, R1
Kim, JM1
Kuo, DJ1
Zitelli, K1
Fernandes, N1
Adams, BB1

Reviews

1 review available for doxepin and Acute Lymphoid Leukemia

ArticleYear
Eosinophilic folliculitis occurring after stem cell transplant for acute lymphoblastic leukemia: a case report and review.
    International journal of dermatology, 2015, Volume: 54, Issue:7

    Topics: Adrenal Cortex Hormones; Doxepin; Eosinophilia; Folliculitis; Histamine Antagonists; Humans; Immunos

2015

Other Studies

1 other study available for doxepin and Acute Lymphoid Leukemia

ArticleYear
Severe medication-induced peripheral neuropathy treated with topical doxepin cream in a paediatric patient with leukaemia.
    BMJ case reports, 2017, May-22, Volume: 2017

    Topics: Administration, Topical; Adolescent; Dosage Forms; Doxepin; Female; Humans; Mucormycosis; Peripheral

2017